The article examines the debate over whether robotic surgery, especially for prostate cancer but also other tumors, is a marketing gimmick or should be accepted as a proven standard of care.
The article examines the debate over whether robotic surgery, especially for prostate cancer but also other tumors, is a marketing gimmick or should be accepted as a proven standard of care.